For the Inventor, By the Inventor

Enter assignee name

Edmonton, Canada

Pulmonox Technologies Corporation

USPTO Granted Patents = 15

% Expired Patents = 20.0

Forward Citations = 832

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Christopher C Miller (9 out of 24 patents)

Alex Stenzler (8 out of 65 patents)

Chris Miller (4 out of 4 patents)

4. Douglas R Hole (3 out of 6 patents)

5. Bevin B McMullin (3 out of 3 patents)

6. Curtis Barry Figley (2 out of 14 patents)

7. Darin Wayne Hunt (2 out of 9 patents)

8. Bruce R Murray (2 out of 3 patents)

9. Bryan Perry (2 out of 4 patents)

10. Robert E Lee (2 out of 2 patents)

11. Michael Hudec (1 out of 1 patent)

12. Robert Rolfson (1 out of 1 patent)

13. Abdi Ghaffari (1 out of 1 patent)

14. Ali Ardakani (1 out of 1 patent)

15. Doug Hole (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 9095534 - Intermittent dosing of nitric oxide gas (2015-08-04),

2. 8795222 - Device and method for treatment of surface infections with nitric oxide (2014-08-05),

3. 8518457 - Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant (2013-08-27),

4. 8079998 - Methods and devices for the delivery of therapeutic gases including nitric oxide (2011-12-20),

5. 8043252 - Nitric oxide decontamination of the upper respiratory tract (2011-10-25),

6. 7955294 - Intermittent dosing of nitric oxide gas (2011-06-07),

7. 7531133 - Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma (2009-05-12),

8. 7520866 - Device and method for treatment of wounds with nitric oxide (2009-04-21),

9. 7516742 - Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing (2009-04-14),

10. 7485324 - Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms (2009-02-03),

11. 7335181 - Nitric oxide decontamination of the upper respiratory tract (2008-02-26),

12. 7255105 - System for use in administrating therapeutic gas to a patient (2007-08-14),

13. 7122018 - Device and method for treatment of wounds with nitric oxide (2006-10-17),

14. 6955171 - System and method for delivering therapeutic gas to a patient (2005-10-18),

15. 6920876 - Device for administration of nitric oxide to horses spontaneously breathing (2005-07-26),

Company Overview

Pulmonox Technologies Corporation, based in Edmonton, Canada, specializes in the development of innovative medical devices aimed at enhancing respiratory care. The company focuses on creating advanced solutions that improve the diagnosis and treatment of pulmonary conditions. By leveraging cutting-edge technology, Pulmonox aims to address critical needs in the healthcare sector, particularly in respiratory health, contributing to better patient outcomes and streamlined clinical workflows.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#19 in Edmonton

#983 in Canada

#39,959 in the World

Edmonton, Canada

Pulmonox Technologies Corporation

Forward Citations = 832

17 inventors:

Christopher C Miller (9 out of 24 patents)

Alex Stenzler (8 out of 65 patents)

Chris Miller (4 out of 4 patents)

4. Douglas R Hole (3 out of 6 patents)

5. Bevin B McMullin (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pulmonox Technologies Corporation. Retrieved from https://idiyas.com/company/pulmonox-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…